Delivery Order SPE2DE24D0013-SPE2D626F60B1
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $8,640 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated XPRS4PLEX-10, contains no set-aside provisions and represents work to be performed at Cepheid's headquarters location in Sunnyvale, California. The contract involves the supply of diagnostic reagents and test kits for Cepheid's GeneXpert platform, which...
- The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $1,750.00 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on November 10, 2025, with an ultimate completion date of November 18, 2025. This delivery order, identified as GXMRSA-NXG-10, was issued without set-aside designation and is to be performed in Sunnyvale, California. Cepheid, a leading manufacturer of advanced molecular diagnostic systems headquartered in Sunnyvale, specializes in infectious...
- The Defense Department's Medical Supply Chain awarded a $57.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 8, 2025, for molecular diagnostic solutions with an ultimate completion date of September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, will be performed in Sunnyvale, California, where Cepheid manufactures its GeneXpert diagnostic systems and associated test kits. This award carries no set-aside designation and represents a continuation of...
- On December 17, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,175.16 to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents. The contract, designated as XPRSMVP-10 with ultimate completion by December 24, 2025, utilizes a firm fixed-price structure with no set-aside designation. The delivery order supports the agency's medical supply chain operations and aligns with...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $13.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of October 3, 2025. This delivery order, which carries no set-aside designation, represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities and equipment. Cepheid specializes in advanced...
- On December 10, 2025, the Defense Logistics Agency Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) for diagnostic testing supplies related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, valued at the ceiling amount, has an ultimate completion date of December 17, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This award includes no set-aside designation and...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,140 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a molecular diagnostics manufacturer based in Sunnyvale, California, on September 18, 2025. The delivery order, identified as GXMRSA-NXG-10, carries an ultimate completion date of October 2, 2025, and involves work to be performed at Cepheid's Sunnyvale facility. This award was made with no set-aside designation, allowing Cepheid to compete on an unrestricted...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, pertains to XPCOV2/FLU/RSV-10 testing capabilities and carries no set-aside designation. The contract represents work performed under Cepheid's larger indefinite delivery vehicles,...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,815.72 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on June 27, 2025, for completion by July 7, 2025. The delivery order, identified as XPRSMVP-10, will be performed in Sunnyvale, California, and carries no set-aside designation. Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, specializes in advanced diagnostic systems and test kits for infectious diseases, genetic...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The award, issued on July 30, 2025, with an ultimate completion date of August 6, 2025, carries no set-aside designation and covers diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Performance will take place at...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F60B1Delivery Order
The Defense Logistics Agency's Medical Supply Chain organization awarded a $1,500 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on December 29, 2025, with an ultimate completion date of January 6, 2026. This delivery order, referenced as GXMRSA-NXG-10 (Contract Number 4570363714), carries no set-aside designation and represents work to be performed at Cepheid's headquarters in Sunnyvale, California. The delivery order procures molecular diagnostic supplies, test kits, or reagents aligned with Cepheid's core competency in advanced diagnostic systems and infectious disease testing solutions. This award builds on Cepheid's extensive federal contracting relationship as a primary supplier of molecular diagnostic capabilities across multiple defense and civilian healthcare agencies. The company maintains significant indefinite delivery contracts with the Department of Veterans Affairs, including a $32.8 million contract with VISN 6 extending through September 2030 and a $6.7 million contract with VISN 17 through December 2029, which have generated numerous delivery orders for diagnostic reagents and testing supplies. Cepheid also holds established contracts with the Defense Health Agency, Indian Health Service, and U.S. Coast Guard, positioning the company as a critical federal supplier for GeneXpert diagnostic systems, molecular testing reagents, and associated maintenance services supporting clinical laboratory operations across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/28/25 |